Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.370
-0.020 (-1.44%)
Mar 6, 2026, 2:32 PM EST - Market open
Marker Therapeutics Employees
Marker Therapeutics had 5 employees as of December 31, 2024. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change (1Y)
-3
Growth (1Y)
-37.50%
Revenue / Employee
$938,998
Profits / Employee
-$2,859,607
Market Cap
22.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| IO Biotech | 78 |
| Boundless Bio | 64 |
| Vistagen Therapeutics | 59 |
| Senti Biosciences | 34 |
| Daré Bioscience | 23 |
| Skye Bioscience | 16 |
| Reviva Pharmaceuticals Holdings | 14 |
MRKR News
- 16 days ago - Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 2 months ago - Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer - GlobeNewsWire
- 4 months ago - Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 months ago - Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors - GlobeNewsWire
- 4 months ago - Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting - GlobeNewsWire
- 5 months ago - Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program - GlobeNewsWire
- 6 months ago - Marker Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Marker Therapeutics Stock Drops After Report About Lymphoma Treatment - Benzinga